Indian pharmaceutical company Lupin announced on Monday that it has secured approval from the US Food and Drug Administration (USFDA) to introduce a generic HIV medication to the American market. The ...

Lupin receives tentative USFDA approval for its generic HIV treatment, combining Darunavir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide. The drug, equivalent to Janssen's Symtuza ...

In the past two days, Lupin stock has surged 8 per cent after the pharmaceutical company received tentative approval from the US Food and Drug Administration (USFDA) to market generic HIV combination ...

According to IQVIA MAT December 2024, this drug will generate a U.S. market sales revenue of $1,374 million. Lupin is the first-to-file applicant for this generic product. Being the first-to-file ...

Lupin gained 3.66% to Rs 2,188 after the company announced that it has received a tentative approval from the U.S. Food and Drug Administration (USFDA) for its ANDA for Darunavir, Cobicistat, ...

Lupin has received USFDA approval for its generic version of Symtuza, a medication for HIV. The product is estimated to have annual sales of USD 1.374 billion in the US. New Delhi, Feb 3 (PTI) Drug ...

Lupin also shared that it has received FDA approval for sacubitril and valsartan tablets, 24 mg/26 mg, 49 mg/51 mg and 97 mg/103 mg, which is the generic of Novartis’ Entresto.

Drug maker Lupin Ltd confirmed on Tuesday that it has received tentative approval from the U.S. Food and Drug Administration (FDA) for its generic version of a combination HIV treatment. The company ...

Lupin has received approval from the Food and Drug Administration for ipratropium bromide nasal solution (nasal spray), 0.06%, which is a generic of Boehringer Ingelheim's Atrovent Nasal Spray, 0.06%.

The arrested accused disclosed that after reaching Kalamboli, the syrup was intended to be distributed to specific buyers. Later, a truck brought the drug consignment to Bhiwandi. Subsequently ...

Here’s a quick look at stocks likely to be in focus in today's trade. Lupin: Drug manufacturer Lupin Ltd. received tentative approval from the U.S. FDA for its generic version of a combination ...